galectins 施加的免疫调节:在罕见的癌症中是一个机会之地
Laura Díaz-Alvarez1,2, Georgina I López-Cortés3, Erandi Pérez-Figueroa4,5
1Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Frontiers in immunology
|November 29, 2023
概括
由于有限的治疗方法,罕见的癌症是致命的. 盖लेक्ट因在向免疫调节疗法方面表现有前途,为这些具有挑战性的疾病提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 罕见的癌症占诊断的很小一部分,但导致不成比例的高癌症死亡人数.
- 有限且非特异性的治疗选择导致罕见癌症患者的治疗结果不佳.
- 用免疫调节剂准瘤微环境是一种有前途的治疗策略.
研究的目的:
- 审查当前关于稀有癌症中加勒胺介导免疫调节的知识.
- 确定研究机会,以开发定制的基于素的疗法.
- 突出加勒素作为罕见恶性瘤的药物点的潜力.
主要方法:
- 对加勒素和罕见癌症研究的文献综述.
- 分析瘤微环境调节中的加勒丁作用.
- 在罕见的恶性瘤中确定向加勒的治疗策略.
主要成果:
- 质素在调节瘤微环境方面发挥着重要作用.
- 通过加勒胺介导的免疫调节为罕见癌症治疗提供了独特的机会.
- 特定的加勒素通路与各种罕见的癌症类型有关.
结论:
- 银素是开发用于罕见癌症的新型免疫疗法的有希望的目标.
- 对加勒特异性治疗的进一步研究是有必要的,以改善患者的治疗结果.
- 有针对性的加勒因疗法可以克服目前罕见癌症治疗的局限性.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K


